Cervical Cancer | Tumor

CURE’s cervical cancer page is an extensive resource of cancer information featuring the latest cervical cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on cervical cancer.

Cancer Vaccine-Tecentriq Combo Elicits ‘Very Encouraging’ Outcomes in Advanced Cervical Cancer

May 10th 2022

Treatment with an investigational cancer vaccine plus Tecentriq was associated with positive outcomes in patients with heavily pre-treated advanced cervical cancer, according to findings from an interim analysis of a phase 2 trial.

Imfinzi Fails to Improve Survival in Locally Advanced Cervical Cancer

March 25th 2022

AstraZeneca, the manufacturer of the drug, announced that treatment with Imfinzi plus chemoradiotherapy did not improve survival compared with standard-of-care chemoradiotherapy alone in patients with locally advanced cervical cancer.

Side Effects From Newer Cervical Cancer Treatments May Seem ‘Daunting’ for Some Patients, But ‘We Will Have a Plan,’ Expert Says

February 3rd 2022

With newer treatments like Keytruda (pembrolizumab) approved for patients with cervical cancer, a younger patient population may be concerned about experiencing side effects that interrupt their lives — but if they occur, clinicians will be ready with a plan for management, says an expert from the Uniformed Services University of the Health Sciences.

When Diagnosed With Cervical Cancer, Single Mom Turns to Advocacy — for Herself, Her Children and Other Survivors

January 20th 2022

In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

How Unexpected Bleeding Lead to a Cervical Cancer Diagnosis: 'I Was Shocked'

January 17th 2022

One woman explains how after experiencing irregular bleeding, she found out she had cervical cancer and her life changed immediately.

FDA Target Dates for Potential Cancer Drug Approvals in Early 2022

January 10th 2022

The Food and Drug Administration is expected to decide on whether to approve certain cancer regimens within the first few months of the year. Here’s what patients with cancer should know.

FDA Approval of Tisotumab Vedotin in Cervical Cancer Provides New Treatment 'Where We've Had Very Few Other Options'

September 24th 2021

The antibody drug conjugate could provide patients with symptomatic relief, along with manageable side effects.

FDA Approves Tivdak for Metastatic/Recurrent Cervical Cancer

September 20th 2021

Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.

Standard Screening Practices May Highlight Disparities in Endometrial Cancer

August 5th 2021

Transvaginal ultrasonography may inaccurately measure uterine lining in Black women, highlighting the potential to assess its use on a case-by-case basis.

WHO Publishes New Cervical Cancer Guidelines

July 6th 2021

Pap tests should be replaced by more accurate HPV DNA tests, the organization says.

Chadwick Boseman’s Brother Performs Dance Tribute, Blink-182’s Mark Hoppus Announces Cancer Diagnosis, And More

June 25th 2021

From a dance tribute performed by Kevin Boseman, late actor Chadwick Boseman’s brother to the humorous coloring book a woman created during treatment for cancer, here’s what’s happening in the cancer landscape this week.

Addition of Chemo After Chemoradiation Fails to Improve Survival in Locally Advanced Cervical Cancer

June 4th 2021

Treatment with chemotherapy following the standard chemoradiation treatment failed to improve multiple survival outcomes in women with locally advanced cervical cancer.

‘Great Deal of Work’ Still Needed to Reverse Increasing Rates of Several HPV-Related Cancers

May 20th 2021

Almost 20 years of data indicate that the incidence of HPV-related cervical cancer is noticeably declining, however other cancers related to the virus continue, and are expected, to increase.

Novel Therapy May Address ‘High Unmet Clinical Need’ in Recurrent/Metastatic Cervical Cancer

April 28th 2021

Treatment with tisotumab vedotin, a novel antibody-drug conjugate, in women with recurrent or metastatic cervical cancer, led to an objective response rate of 24% with a manageable safety profile.

15 Years Later, What Have We Learned About the HPV Vaccine?

March 19th 2021

The HPV vaccine has been shown to help prevent cervical cancer, but what if you didn’t get the vaccine in time to prevent the disease?

People Share Their Thoughts on Getting the HPV Vaccine to Help Prevent Certain Types of Cancer Later in Life

February 15th 2021

On social media, CURE® recently asked its readers to share their thoughts on getting the HPV vaccine to help prevent certain types of cancer later in life. Here is what some of them shared.

HPV Vaccine Substantially Lowers Cervical Cancer Risk, First Patient Cured of HIV Dies from Cancer, and More

October 2nd 2020

From study results demonstrating that the HPV vaccine substantially reduces the risk of cervical cancer to the first person known to be cured of HIV dying from acute myeloid leukemia, here’s what’s happening in the cancer landscape this week.

FDA Approves Expanded Use of CINtec PLUS Cytology Test in Preventing Cervical Cancer

September 16th 2020

The Food and Drug Administration approved the expanded use of the biomarker test CINtec PLUS Cytology that looks at HPV related biomarkers that could lead to cervical cancer. This is the first triage test approved in this space.

Prioritizing Family Health History

April 15th 2020

Make sure to prioritize your family health history to understand your risk of cancer.

Immunotherapy Shows Survival Benefit in Cervical Cancer After Chemoradiotherapy

April 5th 2020

Immunotherapy used after chemoradiotherapy shows better survival outcomes for patients with cervical cancer.

New Biological Approaches Shed Light on the Genomics of Cervical Cancer

March 31st 2020

New biological advances are giving patients and their care teams a better understanding of cervical cancer — a disease that affects thousands each year.

Copper IUD Use Associated with Decreased Cervical Cancer Risk Compared Hormonal Intrauterine System

March 23rd 2020

Women who use copper intrauterine devices (IUD) as a form of birth control may be at lower risk for high-grade cervical cancer compared with those who use a levonorgestrel-releasing intrauterine system.

World Health Organization Outlines Plan to Eliminate Cervical Cancer in Low to Middle Income Countries

February 5th 2020

The World Health Organization has announced a vaccination-based initiative to eliminate cervical cancer as a public health problem in low to middle income countries.

World Cancer Day: 6 Hot Topics Making An Impact In Cancer

February 4th 2020

For World Cancer Day, here are 6 hot topics making an impact in the cancer space.

CURE's Clinical Trial Corner: Cervical Cancer Edition

December 9th 2019

Here is a list of clinical trials that are currently happening within the cervical cancer space.

Women Should Be Screened for Cervical Cancer Even as They Age

November 20th 2019

Recent study findings showed that cervical cancer screening rates declined between ages 45 and 65, even as experts advise that women be screened through their lifetime.

Self-Testing for HPV Could Help Reduce Cervical Cancer Rates

November 15th 2019

A new study suggests distributing self-testing kits by mail helps bring effective testing to underserved populations and makes it easier for women to get tested on their own time.

At-Home Urine Test Could Replace Pap Smear for Cervical Pre-Cancer Screening

November 13th 2019

Results from a new study suggest there may be a simpler, cheaper, more accessible way to screen for cervical pre-cancer.

Examining Genomics in the Treatment of Cervical Cancer

November 12th 2019

Researchers from Yale Cancer Center have created a platform to identify genetic mutations that might drive cervical cancer.

Clinical Trial Is Enrolling Patients With Cervical Cancer for Investigational Immunotherapy

October 23rd 2019

Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.

NEXT PAGE
PREVIOUS PAGE